MY110041A - Composition and method of treating hepatitis c - Google Patents

Composition and method of treating hepatitis c

Info

Publication number
MY110041A
MY110041A MYPI92001633A MYPI19921633A MY110041A MY 110041 A MY110041 A MY 110041A MY PI92001633 A MYPI92001633 A MY PI92001633A MY PI19921633 A MYPI19921633 A MY PI19921633A MY 110041 A MY110041 A MY 110041A
Authority
MY
Malaysia
Prior art keywords
treating hepatitis
composition
thymosins
alone
methods
Prior art date
Application number
MYPI92001633A
Inventor
Chretian Paul
Mutchnick Milton
Original Assignee
Sciclone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc filed Critical Sciclone Pharmaceuticals Inc
Publication of MY110041A publication Critical patent/MY110041A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSITIONS AND METHODS OF USE FOR TREATING HEPATITIS C VIRUS-INFECTED MAMMALS ARE DISCLOSED. THE COMPOSITIONS INCLUDE ONE OR MORE THYMOSINS ALONE OR IN COMBINATION WITH ONE OR MORE INTERFERONS. METHODS OF TREATMENT INCLUDE USE OF THYMOSINS ALONE, OR TOGETHER, OR SEQUENTIALLY WITH INTERFERON.
MYPI92001633A 1991-09-13 1992-09-12 Composition and method of treating hepatitis c MY110041A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US78954491A 1991-09-13 1991-09-13

Publications (1)

Publication Number Publication Date
MY110041A true MY110041A (en) 1997-11-29

Family

ID=79909562

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI92001633A MY110041A (en) 1991-09-13 1992-09-12 Composition and method of treating hepatitis c

Country Status (1)

Country Link
MY (1) MY110041A (en)

Similar Documents

Publication Publication Date Title
CA2119006A1 (en) Composition and method of treating hepatitis c
EP0717592A4 (en) Method and composition for the treatment of apathy-amotivation syndrome
HUT37891A (en) Process for preparing synegretic mixtures of interferones and tumor necrosis factor
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
RO115700B1 (en) Method of treatment with interferon
ZA848973B (en) Enzyme-resistant immunomodulatory peptides
EP0658116A4 (en) Methods useful in endotoxin prophylaxis and therapy.
MY122185A (en) Use of n-substituted-1, 5-dideoxy-1, 5-imino-d-glucitol compounds for treating hepatitis virus infections
EP0596962A4 (en) Therapeutic compositions and methods.
EP0610286A4 (en) Recombinant immunotoxins.
AU6169298A (en) Use of (n)-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combinationtherapy for treating hepatitis virus infections
EP0656791A4 (en) Therapeutic compositions and methods using pqq.
EP0649304A4 (en) Composition and methods for decreasing muscle breakdown.
MX9304209A (en) COMPOSITION AND METHOD OF TREATMENT OF HEPATITIS B.
DE3685484D1 (en)
DK201590D0 (en) ANTI-HYPERTENSIVE HYPERIMMUN MILK, PREPARATION, COMPOSITION AND USE
SG46620A1 (en) Method and composition foor the treatment of autoimmune hepatitis
MD960168A (en) Method for treatment of viral infections and compounds therefor
NO982463L (en) Use of a combination of pentoxyphylline and type I interferons for the treatment of multiple sclerosis
MY110041A (en) Composition and method of treating hepatitis c
GB9010058D0 (en) Method and composition for the treatment of cancer
EP0452360A4 (en) Methods and compositions for the prophylaxis and treatment of hepatitis b virus infections
AU2434992A (en) Methods and compositions for treating sunburns
FI901607A0 (en) LEEKEMEDEL OCH DESS ANVAENDNING FOER BEHANDLING AV PARASITOS.
GR3005553T3 (en)